These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. McTaggart SJ, Atkinson K. Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660 [Abstract] [Full Text] [Related]
4. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [Abstract] [Full Text] [Related]
15. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity. Li N, Feugier P, Serrurrier B, Latger-Cannard V, Lesesve JF, Stoltz JF, Eljaafari A. Exp Hematol; 2007 Mar; 35(3):507-15. PubMed ID: 17309831 [Abstract] [Full Text] [Related]
16. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Tonti GA, Mannello F. Int J Dev Biol; 2008 Mar; 52(8):1023-32. PubMed ID: 18956335 [Abstract] [Full Text] [Related]
17. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Arthur A, Zannettino A, Gronthos S. J Cell Physiol; 2009 Feb; 218(2):237-45. PubMed ID: 18792913 [Abstract] [Full Text] [Related]